The purpose of this Program Project is to bring together collective expertise in the areas of molecular biology, biochemistry and immunology, and in vitro and in vivo models of mycobacterial disease, in order to accumulate fundamental knowledge leading to a better understanding of the nature of Mycobacterium avium, including the identification of drug targets, whereby colonization and subsequent disseminated disease in AIDS patients can be successfully treated. Project 1 will pursue the biochemistry of M. avium in order to provide a detailed chemical knowledge of the cell wall barrier, including those components unique to the group of mycobacterial which may comprise specific drug targets. In addition, it will investigate the basis of colony morphotypes, including the growing body of evidence that relates the expression of the glycopeptidolipids to persistence and virulence of the infection and resistance to chemotherapy. Project 2 will address similar problems at the genomic level, specifically, the cloning and analysis of genes for potential drug targets including genes that encode essential enzyme systems and control the synthesis of structures that determine morphotype, and hence potentially contribute to the virulence of the organism and pathogenesis of disease. Project 3 will continue to develop innovative animal models of M. avium infection, models that most closely mimic the clinical situation in immunodeficient AIDS patients. It will document the pathological process of colonization, leading to active infection and disseminated disease in T cell-deficient mice, and will relate this information to the molecular, biochemical, and morphological properties of the isolate or variant. In addition, it will provide a resource for the in vivo testing of potentially efficacious compounds identified in Project 4. This last Project will directly address the question of identifying drugs with activity against specific targets, by combining computer modeling techniques with a sophisticated panel of in vitro activity assays, prior to the testing of such agents in animal models of infection.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01AI030189-04
Application #
3547593
Study Section
Special Emphasis Panel (SRC (76))
Project Start
1990-08-01
Project End
1995-07-31
Budget Start
1993-08-01
Budget End
1994-07-31
Support Year
4
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Colorado State University-Fort Collins
Department
Type
Schools of Veterinary Medicine
DUNS #
112617480
City
Fort Collins
State
CO
Country
United States
Zip Code
80523
Xin, Y; Lee, R E; Scherman, M S et al. (1997) Characterization of the in vitro synthesized arabinan of mycobacterial cell walls. Biochim Biophys Acta 1335:231-4
Lee, R E; Armour, J W; Takayama, K et al. (1997) Mycolic acid biosynthesis: definition and targeting of the Claisen condensation step. Biochim Biophys Acta 1346:275-84
Venkataprasad, N; Jacobs, M R; Johnson, J L et al. (1997) Activity of new quinolones against intracellular Mycobacterium avium in human monocytes. J Antimicrob Chemother 40:841-5
Belanger, A E; Besra, G S; Ford, M E et al. (1996) The embAB genes of Mycobacterium avium encode an arabinosyl transferase involved in cell wall arabinan biosynthesis that is the target for the antimycobacterial drug ethambutol. Proc Natl Acad Sci U S A 93:11919-24
Klopman, G; Fercu, D; Renau, T E et al. (1996) N-1-tert-butyl-substituted quinolones: in vitro anti-Mycobacterium avium activities and structure-activity relationship studies. Antimicrob Agents Chemother 40:2637-43
Klopman, G; Fercu, D; Li, J Y et al. (1996) Antimycobacterial quinolones: a comparative analysis of structure-activity and structure-cytotoxicity relationships. Res Microbiol 147:86-96
Shiratsuchi, H; Jacobs, M R; Pearson, A J et al. (1996) Comparison of the activity of fluoroquinolones against Mycobacterium avium in cell-free systems and a human monocyte in-vitro infection model. J Antimicrob Chemother 37:491-500
Mikusova, K; Mikus, M; Besra, G S et al. (1996) Biosynthesis of the linkage region of the mycobacterial cell wall. J Biol Chem 271:7820-8
Dubnau, E; Soares, S; Huang, T J et al. (1996) Overproduction of mycobacterial ribosomal protein S13 induces catalase/peroxidase activity and hypersensitivity to isoniazid in Mycobacterium smegmatis. Gene 170:17-22
Dessen, A; Quemard, A; Blanchard, J S et al. (1995) Crystal structure and function of the isoniazid target of Mycobacterium tuberculosis. Science 267:1638-41

Showing the most recent 10 out of 40 publications